Volcon Stock (NASDAQ:VLCN), Trade Ideas

Volcon

Volcon Inc is an all-electric, off-road powersports vehicle company developing and building electric two and four-wheel motorcycles and utility terrain vehicles, also known as side-by-sides, along with a complete line of upgrades and accessories. The company's products include motorcycle and UTV products that are all-electric and designed for off-road use. The company has hundred and three dealers covering twenty eight states.

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

ACIC

ADIL

ARVN

BIVI

CRDF

DCFC

DELL

DMTK

DTIL

ESTC

EVBG

GRTS

HLTH

HUMA

JAGX

JAKK

LIFW

MINM

NTAP

NYCB

OPRA

RDNT

REAL

RGNX

RILY

RMBS

ROOT

RPAY

SANA

SCLX

SENS

SIDU

SOUN

TTEC

VANI

VLCN

VTYX

XPOF

YMAB

Shares of  Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-quarter results.

Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday&#39;s Mid-Day Session

AGFY

AMRN

ARRY

AUMN

BBWI

BCAN

BEDU

BFLY

Bakkt Holdings, Inc. Class A Common Stock

BKKT

BLUE

CMPS

COMM

CRML

CSTL

CTKB

DAVA

DUOL

ENVB

ESTA

FIGS

GRFS

GYRE

HAYW

IHRT

INDP

INSG

IONQ

IRWD

LPSN

MGNI

MIST

MRSN

NARI

NTES

NWTN

OCEA

OKTA

ORIC

PSTG

PZZA

QURE

RNLX

RVNC

SCTL

SDGR

SHLS

SNOW

STER

STKL

SWIM

TASK

VERX

XMTR

Shares of  Butterfly Network, Inc.  (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results.

Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday&#39;s Mid-Day Session

VLCN, Volcon

Earnings

Equities

Guidance

General

Volcon shares surge after delivering first production vehicle, Volcon Stag, to US Army Corps of Engineers for evaluation and testing.

EV Maker Volcon&#39;s Stock Jumps - What&#39;s Going On?

Volcon Inc

<p>Over the past 24 hours, <strong>dogwifhat's</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">WIF</a>) price has risen 17.82% to <strong>$3.02</strong>. This continues its positive trend over the past week where it has experienced a 13.0% gain, moving from $2.69 to its current price. As it stands right now, <strong>the coin's all-time high is $4.83</strong>. </p>
<p>The chart below compares the price movement and volatility for dogwifhat over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1713553356_0.png" alt="price_chart" /></p>
<p>The trading volume for the coin has risen 51.0% over the past week diverging from the circulating supply of the coin, which has decreased 0.16%. This brings the circulating supply to 998.93 million, which makes up an estimated 100.0% of its max supply of 998.93 million. According to our data, the current market cap ranking for WIF is #39 at $3.02 billion.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1713553356_1.png" alt="supply_and_vol" /></p>
<p><a href="https://www.coingecko.com/en/api">Powered by CoinGecko API</a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$WIF

Cryptocurrency dogwifhat's Price Increased More Than 17% Within 24 hours

<p><strong>Vision Sensing Acquisition Corp. (NASDAQ:</strong><a href="https://www.benzinga.com/stock/VSACU#NASDAQ"><strong>VSACU</strong></a><strong>, VSAC, VSACW)))</strong> (the "<strong>Company</strong>" or "<strong>VSAC</strong>"), a special purpose acquisition company, issues an update regarding the previously announced staff determination letter (the "Letter") received on&nbsp;January 17, 2024, from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("<strong>Nasdaq</strong>") notifying the Company of the determination from the Nasdaq Staff (the "<strong>Staff</strong>").<br /><br />&nbsp;</p>
<p>As stated, the Letter was issued to the Company as the Company is not in compliance with the market value requirement as set forth Listing Rule 5450(b)(2)(A) (the "<strong>Market Value Requirement</strong>"), and the minimum 400 total holders requirement, as is required by Listing Rule 5450(a)(2) (the "<strong>Total Holders Requirement</strong>"). The Letter also states that the Company has not yet filed its Form 10-Q for the period ended September 30, 2023 (the "<strong>Filing</strong>") and is therefore not in compliance with Listing Rule 5250(c)(1).</p>
<p>On January 23, 2024, the Company submitted an appeal to the appeal Staff's determination to a Hearings Panel (the "<strong>Panel</strong>"), pursuant to the procedures set forth in the Nasdaq Listing Rule 5800 Series. This submission included a detailed Compliance Plan, to present to the Panel, to regain compliance with the Listing Rules and also requested a stay of the suspension of the Company's securities. The Hearing request has stayed the suspension of the Company's securities and the filing of the Form 25-NSE with the Securities and Exchange Commission (the "SEC"). On January 24, 2024, the Company was notified, by the Nasdaq Hearings Advisor, that the hearing is scheduled to be held on April 4, 2024. The Company's securities are still eligible to trade on Nasdaq.</p>
<p>VSAC noted that the deficiencies related to the Market Value Requirement and the Total Holders Requirement are common for SPACs at the Company's current stage of completing a planned transaction. In its Compliance Plan submitted to Staff, VSAC has noted that the recently announced business combination with Mediforum Co., Ltd. ("<strong>Mediforum</strong>") will automatically resolve these deficiencies. The Company also noted that, if necessary, it can also consider implementing alternative solutions to the deficiencies to regain compliance with (a) the Market Value Requirement, by converting its Series B shares into Series A shares coupled with moving the company's listing to the Nasdaq Capital Market and (b) the Total Holders Requirement, by working with outside agencies to increase the number of Total Holders to above the minimum requirement.</p>
<p>On, February 7, 2024, the Company filed the outstanding 10-Q and regained compliance with Listing Rule 5250(c)(1).</p>
<p>On April 4, 2024, the Company met with the Nasdaq Hearings Panel ("Panel") and the Company management addressed Staff's concerns regarding timing issues in the business combination and presented a viable, concrete plan to regain compliance within the Panel's discretionary period while continuing to pursue a business combination.</p>
<p>On April 17, 2024, the Panel granted the request of VSAC to continue its listing on The Nasdaq Stock Market subject to the condition that on or before July 15, 2024, the Company will transfer its listing from the Nasdaq Global Market to the Nasdaq Capital Market and comply with all the applicable listing requirements of the Nasdaq Capital Market.&nbsp; The Company must provide prompt notification of any significant events that occur during this period that may affect the Company's compliance with the Nasdaq requirements, and the Nasdaq Hearing Panel reserves the right to reconsider the extension based on any event, condition or circumstance that exists or develops that would, in the opinion of the panel, make continued listing of the Company's securities on Nasdaq inadvisable or unwarranted.&nbsp; The Company intends to vigorously pursue its plan to return to compliance with the Nasdaq listing criteria on or prior to July 15, 2024.</p>
<p>The press release shall not be deemed "filed" for any purpose, including for the purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that Section. The information in this Item 7.01, including Exhibit 99.1, shall not be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act regardless of any general incorporation language in the filing.</p>


VSAC

On April 17, 2024, The Panel Granted The Request Of VSAC To Continue Its Listing On The Nasdaq Stock Market Subject To The Condition That On Or Before July 15, 2024, The Co Will Transfer Its Listing From The Nasdaq Global Market To The Nasdaq Capital Market And Comply With All The Applicable Listing Requirements Of The Nasdaq Capital Market

<p>Financial giants have made a conspicuous bullish move on Medical Properties Trust. Our analysis of options history for Medical Properties Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPW#NYSE">MPW</a>) revealed 10 unusual trades.</p>
<p>Delving into the details, we found 50% of traders were bullish, while 50% showed bearish tendencies. Out of all the trades we spotted, 6 were puts, with a value of $380,398, and 4 were calls, valued at $342,493.</p>
<h3>Projected Price Targets</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $1.0 to $5.0 for Medical Properties Trust over the recent three months. </p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Medical Properties Trust's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Medical Properties Trust's substantial trades, within a strike price spectrum from $1.0 to $5.0 over the preceding 30 days.</p>
<h3>Medical Properties Trust Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1713553351_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>MPW</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/17/24</td>
<td>$0.22</td>
<td>$0.21</td>
<td>$0.22</td>
<td>$4.00</td>
<td>$197.4K</td>
<td>49.8K</td>
<td>649</td>
</tr>
<tr>
<td>MPW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/19/24</td>
<td>$0.59</td>
<td>$0.54</td>
<td>$0.54</td>
<td>$5.00</td>
<td>$132.1K</td>
<td>14.4K</td>
<td>2.7K</td>
</tr>
<tr>
<td>MPW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/17/24</td>
<td>$2.06</td>
<td>$1.5</td>
<td>$1.81</td>
<td>$3.00</td>
<td>$123.6K</td>
<td>366</td>
<td>17</td>
</tr>
<tr>
<td>MPW</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/19/24</td>
<td>$0.38</td>
<td>$0.35</td>
<td>$0.35</td>
<td>$5.00</td>
<td>$70.2K</td>
<td>9.7K</td>
<td>4.8K</td>
</tr>
<tr>
<td>MPW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/21/24</td>
<td>$0.46</td>
<td>$0.36</td>
<td>$0.41</td>
<td>$5.00</td>
<td>$59.7K</td>
<td>48.2K</td>
<td>1.8K</td>
</tr>
</tbody>
</table>
</p>
<h3>About Medical Properties Trust</h3>
<p>Medical Properties Trust Inc is a healthcare facility REIT. The company operates one segment, which owns and leases healthcare facilities. The vast majority of Medical's revenue is generated in the United States, followed by Germany and the United Kingdom. It provides financing for a variety of facilities that require funds for acquisitions, sale-leasebacks, new developments, and expansion projects.</p>
<h3>Medical Properties Trust's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 13,323,502, the MPW's price is down by -7.23%, now at $4.49. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 14 days.</li>
</ul>
<h3>Expert Opinions on Medical Properties Trust</h3>
<p>In the last month, 3 experts released ratings on this stock with an average target price of $4.833333333333333.</p>
<ul>
<li>An analyst from Colliers Securities persists with their Neutral rating on Medical Properties Trust, maintaining a target price of $5. </li>
<li>An analyst from Truist Securities persists with their Hold rating on Medical Properties Trust, maintaining a target price of $4. </li>
<li>Showing optimism, an analyst from Deutsche Bank upgrades its rating to Hold with a revised price target of $5. </li>
</ul>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Medical Properties Trust, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Options

Medical Properties Trust's Options Frenzy: What You Need to Know

<p><strong>Stacks's</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/stx/usd">STX</a>) price has increased 3.92% over the past 24 hours to <strong>$2.5</strong>, which is in the opposite direction of its trend over the past week, where it has experienced a 4.0% loss, moving from $2.62 to its current price.  As it stands right now, <strong>the coin's all-time high is $3.86</strong>. </p>
<p>The chart below compares the price movement and volatility for Stacks over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1713553346_0.png" alt="price_chart" /></p>
<p>The trading volume for the coin has decreased 35.0% over the past week, while the overall circulating supply of the coin has increased 3.88% to over 1.45 billion. This puts its current circulating supply at an estimated 79.95% of its max supply, which is 1.82 billion. The current market cap ranking for STX is #29 at $3.63 billion.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1713553346_1.png" alt="supply_and_vol" /></p>
<p><a href="https://www.coingecko.com/en/api">Powered by CoinGecko API</a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


$STX

Cryptocurrency Stacks's Price Increased More Than 3% Within 24 hours

<p>Investors with a lot of money to spend have taken a bullish stance on <strong>U.S. Bancorp</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USB#NYSE">USB</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with USB, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 15 uncommon options trades for U.S. Bancorp.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 53% bullish and 46%, bearish.</p>
<p>Out of all of the special options we uncovered, 4 are puts, for a total amount of $118,483, and 11 are calls, for a total amount of $384,666.</p>
<h3>Predicted Price Range</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $35.0 to $50.0 for U.S. Bancorp over the last 3 months. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for U.S. Bancorp's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of U.S. Bancorp's whale activity within a strike price range from $35.0 to $50.0 in the last 30 days. </p>
<h3>U.S. Bancorp Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1713553345_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>USB</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$7.3</td>
<td>$7.25</td>
<td>$7.25</td>
<td>$35.00</td>
<td>$97.8K</td>
<td>1.9K</td>
<td>136</td>
</tr>
<tr>
<td>USB</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$2.76</td>
<td>$2.72</td>
<td>$2.76</td>
<td>$42.50</td>
<td>$34.7K</td>
<td>159</td>
<td>705</td>
</tr>
<tr>
<td>USB</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/20/24</td>
<td>$1.92</td>
<td>$1.89</td>
<td>$1.92</td>
<td>$37.50</td>
<td>$34.1K</td>
<td>569</td>
<td>712</td>
</tr>
<tr>
<td>USB</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$2.8</td>
<td>$2.78</td>
<td>$2.78</td>
<td>$42.50</td>
<td>$32.2K</td>
<td>159</td>
<td>1.0K</td>
</tr>
<tr>
<td>USB</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/20/24</td>
<td>$1.89</td>
<td>$1.88</td>
<td>$1.88</td>
<td>$37.50</td>
<td>$31.2K</td>
<td>569</td>
<td>400</td>
</tr>
</tbody>
</table>
</p>
<h3>About U.S. Bancorp</h3>
<p>As a diversified financial-services provider, U.S. Bancorp is one of the nation's largest regional banks, with branches in roughly 26 states, primarily in the Western and Midwestern United States. The bank offers many services, including retail banking, commercial banking, trust and wealth services, credit cards, mortgages, and other payments capabilities.</p>
<p>After a thorough review of the options trading surrounding U.S. Bancorp, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>U.S. Bancorp's Current Market Status</h3>
<ul>
<li>Trading volume stands at 7,094,270, with USB's price up by 1.48%, positioned at $40.02.</li>
<li>RSI indicators show the stock to be may be approaching oversold.</li>
<li>Earnings announcement expected in 89 days.</li>
</ul>
<h3>Expert Opinions on U.S. Bancorp</h3>
<p>5 market experts have recently issued ratings for this stock, with a consensus target price of $49.6.</p>
<ul>
<li>Consistent in their evaluation, an analyst from UBS keeps a Neutral rating on U.S. Bancorp with a target price of $43. </li>
<li>An analyst from Barclays persists with their Overweight rating on U.S. Bancorp, maintaining a target price of $52. </li>
<li>Maintaining their stance, an analyst from Evercore ISI Group continues to hold a In-Line rating for U.S. Bancorp, targeting a price of $48. </li>
<li>Maintaining their stance, an analyst from Keefe, Bruyette &amp; Woods continues to hold a Outperform rating for U.S. Bancorp, targeting a price of $52. </li>
<li>An analyst from HSBC has elevated its stance to Buy, setting a new price target at $53. </li>
</ul>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for U.S. Bancorp with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


Market Whales and Their Recent Bets on USB Options

<p>Deep-pocketed investors have adopted a bearish approach towards Chipotle Mexican Grill (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMG#NYSE">CMG</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in CMG usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 62 extraordinary options activities for Chipotle Mexican Grill. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 30% leaning bullish and 69% bearish. Among these notable options, 29 are puts, totaling $2,542,575, and 33 are calls, amounting to $2,068,378.</p>
<h3>Predicted Price Range</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $1845.0 to $3700.0 for Chipotle Mexican Grill over the last 3 months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for Chipotle Mexican Grill's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Chipotle Mexican Grill's whale activity within a strike price range from $1845.0 to $3700.0 in the last 30 days. </p>
<h3>Chipotle Mexican Grill 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1713553340_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th style="text-align: right;"><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>CMG</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$279.0</td>
<td>$275.0</td>
<td>$275.0</td>
<td>$2950.00</td>
<td>$330.0K</td>
<td style="text-align: right;">128</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>CMG</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$285.8</td>
<td>$285.0</td>
<td>$285.0</td>
<td>$2950.00</td>
<td>$285.0K</td>
<td style="text-align: right;">128</td>
<td style="text-align: right;">22</td>
</tr>
<tr>
<td>CMG</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$203.0</td>
<td>$201.3</td>
<td>$203.0</td>
<td>$2800.00</td>
<td>$243.6K</td>
<td style="text-align: right;">213</td>
<td style="text-align: right;">12</td>
</tr>
<tr>
<td>CMG</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$201.0</td>
<td>$200.2</td>
<td>$201.0</td>
<td>$2800.00</td>
<td>$241.2K</td>
<td style="text-align: right;">213</td>
<td style="text-align: right;">12</td>
</tr>
<tr>
<td>CMG</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$205.0</td>
<td>$204.2</td>
<td>$205.0</td>
<td>$2800.00</td>
<td>$205.0K</td>
<td style="text-align: right;">213</td>
<td style="text-align: right;">24</td>
</tr>
</tbody>
</table>
</p>
<h3>About Chipotle Mexican Grill</h3>
<p>Chipotle Mexican Grill is the largest fast-casual chain restaurant in the United States, with systemwide sales of $9.9 billion in 2023. The Mexican concept is predominately company-owned (it recently inked a development agreement with Alshaya Group in the Middle East), with a footprint of nearly 3,440 stores at the end of 2023, heavily indexed to the United States, although the firm maintains a small presence in Canada, the U.K., France, and Germany. Chipotle sells burritos, burrito bowls, tacos, quesadillas, and beverages, with a selling proposition built around competitive prices, high-quality food sourcing, speed of service, and convenience. The company generates its revenue entirely from restaurant sales and delivery fees.</p>
<p>Having examined the options trading patterns of Chipotle Mexican Grill, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Present Market Standing of Chipotle Mexican Grill</h3>
<ul>
<li>Trading volume stands at 210,533, with CMG's price down by -1.99%, positioned at $2850.05.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 5 days.</li>
</ul>
<h3>What Analysts Are Saying About Chipotle Mexican Grill</h3>
<p>A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $3128.8.</p>
<ul>
<li>Maintaining their stance, an analyst from Morgan Stanley continues to hold a Equal-Weight rating for Chipotle Mexican Grill, targeting a price of $2986. </li>
<li>An analyst from Evercore ISI Group has decided to maintain their Outperform rating on Chipotle Mexican Grill, which currently sits at a price target of $3200. </li>
<li>Maintaining their stance, an analyst from Citigroup continues to hold a Buy rating for Chipotle Mexican Grill, targeting a price of $3358. </li>
<li>An analyst from UBS has decided to maintain their Buy rating on Chipotle Mexican Grill, which currently sits at a price target of $3400. </li>
<li>Maintaining their stance, an analyst from Jefferies continues to hold a Hold rating for Chipotle Mexican Grill, targeting a price of $2700. </li>
</ul>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Chipotle Mexican Grill, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Chipotle Mexican Grill Options Trading: A Deep Dive into Market Sentiment

<p>Throughout the last three months, 4 analysts have evaluated Alpine Income Prop Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PINE#NYSE">PINE</a>), offering a diverse set of opinions from bullish to bearish.</p>
<p>In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $18.69, a high estimate of $19.00, and a low estimate of $18.00. Highlighting a 3.31% decrease, the current average has fallen from the previous average price target of $19.33. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1713553337_0.png" alt="price target chart" /></p>
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
<p>The analysis of recent analyst actions sheds light on the perception of Alpine Income Prop Trust by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Nathan Jones</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$18.75</td>
<td>$19.00</td>
</tr>
<tr>
<td>Jason Weaver</td>
<td>JonesTrading</td>
<td>Lowers</td>
<td>Buy</td>
<td>$18.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>Gaurav Mehta</td>
<td>Alliance Global Partners</td>
<td>Announces</td>
<td>Buy</td>
<td>$19.00</td>
<td>-</td>
</tr>
<tr>
<td>Jason Weaver</td>
<td>JonesTrading</td>
<td>Lowers</td>
<td>Buy</td>
<td>$19.00</td>
<td>$20.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Alpine Income Prop Trust. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Alpine Income Prop Trust compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
<p>Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Alpine Income Prop Trust's market standing. Stay informed and make data-driven decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/PINE/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Alpine Income Prop Trust analyst ratings.</strong></a></p>
<p>If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.</p>
<h2>About Alpine Income Prop Trust</h2>
<p>Alpine Income Property Trust Inc is a real estate company. It owns and operates a portfolio of single-tenant commercial properties. The company's portfolio is comprised of single-tenant retail and office properties located in or in close proximity to MSAs, growth markets and other markets in the United States. Their portfolio consists of One thirty eight net leased properties located in Hundred and four markets in thirty five states. The majority of the firm's revenue includes rental revenue derived from the ownership and leasing of property.</p>
<h3>A Deep Dive into Alpine Income Prop Trust's Financials</h3>
<p><strong>Market Capitalization:</strong> Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.</p>
<p><strong>Decline in Revenue:</strong> Over the 3 months period, Alpine Income Prop Trust faced challenges, resulting in a decline of approximately <strong>-4.62%</strong> in revenue growth as of 31 December, 2023. This signifies a reduction in the company's top-line earnings. When compared to others in the Real Estate sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> Alpine Income Prop Trust's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>3.03%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of <strong>0.13%,</strong> the company showcases effective utilization of equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Alpine Income Prop Trust's ROA stands out, surpassing industry averages. With an impressive ROA of <strong>0.06%</strong>, the company demonstrates effective utilization of assets and strong financial performance.</p>
<p><strong>Debt Management:</strong> Alpine Income Prop Trust's debt-to-equity ratio is below the industry average at <strong>1.12</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<h2>How Are Analyst Ratings Determined?</h2>
<p>Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.</p>
<p>Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Analyst Ratings

PINE

Evaluating Alpine Income Prop Trust: Insights From 4 Financial Analysts

<p>5 analysts have shared their evaluations of PubMatic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PUBM#NASDAQ">PUBM</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.</p>
<p>In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $26.2, a high estimate of $27.00, and a low estimate of $25.00. This current average has increased by 35.54% from the previous average price target of $19.33. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1713553325_0.png" alt="price target chart" /></p>
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
<p>An in-depth analysis of recent analyst actions unveils how financial experts perceive PubMatic. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Daniel Day</td>
<td>B. Riley Securities</td>
<td>Announces</td>
<td>Buy</td>
<td>$27.00</td>
<td>-</td>
</tr>
<tr>
<td>Matthew Swanson</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$26.00</td>
<td>-</td>
</tr>
<tr>
<td>Andrew Boone</td>
<td>JMP Securities</td>
<td>Raises</td>
<td>Market Outperform</td>
<td>$25.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Matthew Swanson</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$26.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>Daniel Day</td>
<td>B. Riley Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$27.00</td>
<td>$21.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to PubMatic. This offers insight into analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of PubMatic compared to the broader market.</li>
<li><strong>Price Targets:</strong> Understanding forecasts, analysts offer estimates for PubMatic's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
<p>Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of PubMatic's market standing. Stay informed and make data-driven decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/PUBM/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on PubMatic analyst ratings.</strong></a></p>
<p>If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.</p>
<h2>Unveiling the Story Behind PubMatic</h2>
<p>PubMatic is one of the leading supply-side platform providers in the digital advertising technology market. These platforms help publishers, which supply digital ad inventory, better manage their inventory, selling a high percentage of their inventory (increase the ad fill rate) and maximizing revenue per ad sold (optimize yield). PubMatic generates revenue mainly via taking a piece of the ad sales that it enables. Buyers on the platform include intermediary buyers, such as demand-side platforms, or advertisers and ad agencies directly. Given the growth in overall digital advertising, more publishers and advertisers are adopting programmatic (or automated) buying and selling, driving the firm's success in attracting more inventory.</p>
<h3>PubMatic: A Financial Overview</h3>
<p><strong>Market Capitalization Analysis:</strong> Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Over the 3 months period, PubMatic showcased positive performance, achieving a revenue growth rate of <strong>13.87%</strong> as of 31 December, 2023. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Communication Services sector.</p>
<p><strong>Net Margin:</strong> PubMatic's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>22.11%</strong> net margin, the company effectively manages costs and achieves strong profitability.</p>
<p><strong>Return on Equity (ROE):</strong> PubMatic's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>6.4%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> PubMatic's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of <strong>2.86%,</strong> the company showcases efficient use of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> PubMatic's debt-to-equity ratio is below the industry average at <strong>0.07</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<h2>Understanding the Relevance of Analyst Ratings</h2>
<p>Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. </p>
<p>In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


PUBM

Analyst Scoreboard: 5 Ratings For PubMatic

<p><strong>Filecoin's</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/fil/usd">FIL</a>) price has increased 4.11% over the past 24 hours to <strong>$6.19</strong>, which is in the opposite direction of its trend over the past week, where it has experienced a 2.0% loss, moving from $6.37 to its current price.  As it stands right now, <strong>the coin's all-time high is $236.84</strong>. </p>
<p>The chart below compares the price movement and volatility for Filecoin over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1713553276_0.png" alt="price_chart" /></p>
<p>The trading volume for the coin has decreased 34.0% over the past week, while the overall circulating supply of the coin has increased 2.18% to over 539.96 million. This puts its current circulating supply at an estimated 27.54% of its max supply, which is 1.96 billion. The current market cap ranking for FIL is #32 at $3.34 billion.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1713553276_1.png" alt="supply_and_vol" /></p>
<p><a href="https://www.coingecko.com/en/api">Powered by CoinGecko API</a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


$FIL

Cryptocurrency Filecoin's Price Increased More Than 4% Within 24 hours

<p>During the last three months, 13 analysts shared their evaluations of American Intl Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIG#NYSE">AIG</a>), revealing diverse outlooks from bullish to bearish.</p>
<p>The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $81.85, with a high estimate of $89.00 and a low estimate of $74.00. Witnessing a positive shift, the current average has risen by 6.3% from the previous average price target of $77.00.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1713553271_0.png" alt="price target chart" /></p>
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
<p>The perception of American Intl Gr by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Paul Newsome</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$89.00</td>
<td>$87.00</td>
</tr>
<tr>
<td>Michael Ward</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$87.00</td>
<td>$79.00</td>
</tr>
<tr>
<td>Michael Phillips</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$79.00</td>
<td>$72.00</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$80.00</td>
<td>$74.00</td>
</tr>
<tr>
<td>David Motemaden</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>In-Line</td>
<td>$80.00</td>
<td>$74.00</td>
</tr>
<tr>
<td>Meyer Shields</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$86.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>Yaron Kinar</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$80.00</td>
<td>$73.00</td>
</tr>
<tr>
<td>Paul Newsome</td>
<td>Piper Sandler</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$87.00</td>
<td>-</td>
</tr>
<tr>
<td>Brian Meredith</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$84.00</td>
<td>$83.00</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$74.00</td>
<td>$66.00</td>
</tr>
<tr>
<td>Joshua Shanker</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Neutral</td>
<td>$77.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Scott Heleniak</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$80.00</td>
<td>$76.00</td>
</tr>
<tr>
<td>Michael Zaremski</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$81.00</td>
<td>$83.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to American Intl Gr. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of American Intl Gr compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
<p>Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into American Intl Gr's market standing. Stay informed and make well-considered decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/AIG/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on American Intl Gr analyst ratings.</strong></a></p>
<h2>Discovering American Intl Gr: A Closer Look</h2>
<p>American International Group is one of the largest insurance and financial services firms in the world and has a global footprint. It operates through a wide range of subsidiaries that provide property, casualty, and life insurance. The company recently spun off its life insurance operations (Corebridge), but still retains a majority stake.</p>
<h3>A Deep Dive into American Intl Gr's Financials</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.</p>
<p><strong>Revenue Challenges:</strong> American Intl Gr's revenue growth over 3 months faced difficulties. As of 31 December, 2023, the company experienced a decline of approximately <strong>-16.78%</strong>. This indicates a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.</p>
<p><strong>Net Margin:</strong> American Intl Gr's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of <strong>0.86%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> American Intl Gr's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of <strong>0.2%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of <strong>0.02%,</strong> the company may need to address challenges in generating satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> American Intl Gr's debt-to-equity ratio surpasses industry norms, standing at <strong>0.5</strong>. This suggests the company carries a substantial amount of debt, posing potential financial challenges.</p>
<h2>Analyst Ratings: What Are They?</h2>
<p>Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.</p>
<p>Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Decoding 13 Analyst Evaluations For American Intl Gr

<p>In the preceding three months, 16 analysts have released ratings for Dynatrace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DT#NYSE">DT</a>), presenting a wide array of perspectives from bullish to bearish.</p>
<p>Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">8</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Analysts have set 12-month price targets for Dynatrace, revealing an average target of $64.38, a high estimate of $70.00, and a low estimate of $52.00. This upward trend is apparent, with the current average reflecting a 4.01% increase from the previous average price target of $61.90.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1713553248_0.png" alt="price target chart" /></p>
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
<p>The standing of Dynatrace among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Andrew Sherman</td>
<td>TD Cowen</td>
<td>Lowers</td>
<td>Buy</td>
<td>$58.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>Pinjalim Bora</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$60.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Raimo Lenschow</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$52.00</td>
<td>$59.00</td>
</tr>
<tr>
<td>Allan Verkhovski</td>
<td>Wolfe Research</td>
<td>Announces</td>
<td>Outperform</td>
<td>$60.00</td>
<td>-</td>
</tr>
<tr>
<td>Sanjit Singh</td>
<td>Morgan Stanley</td>
<td>Announces</td>
<td>Equal-Weight</td>
<td>$60.00</td>
<td>-</td>
</tr>
<tr>
<td>Pinjalim Bora</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$65.00</td>
<td>$69.00</td>
</tr>
<tr>
<td>Patrick Colville</td>
<td>Scotiabank</td>
<td>Lowers</td>
<td>Sector Outperform</td>
<td>$65.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Matthew Hedberg</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$66.00</td>
<td>-</td>
</tr>
<tr>
<td>Blair Abernethy</td>
<td>Rosenblatt</td>
<td>Maintains</td>
<td>Buy</td>
<td>$65.00</td>
<td>-</td>
</tr>
<tr>
<td>Mike Cikos</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$70.00</td>
<td>-</td>
</tr>
<tr>
<td>Blair Abernethy</td>
<td>Rosenblatt</td>
<td>Raises</td>
<td>Buy</td>
<td>$65.00</td>
<td>$58.00</td>
</tr>
<tr>
<td>Patrick Colville</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Outperform</td>
<td>$70.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>Erik Suppiger</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$68.00</td>
<td>-</td>
</tr>
<tr>
<td>Erik Suppiger</td>
<td>JMP Securities</td>
<td>Raises</td>
<td>Market Outperform</td>
<td>$68.00</td>
<td>$56.00</td>
</tr>
<tr>
<td>Mike Cikos</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$70.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Fatima Boolani</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$68.00</td>
<td>$58.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Dynatrace. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Dynatrace compared to the broader market.</li>
<li><strong>Price Targets:</strong> Delving into movements, analysts provide estimates for the future value of Dynatrace's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
<p>Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Dynatrace's market standing. Stay informed and make data-driven decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/DT/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Dynatrace analyst ratings.</strong></a></p>
<h2>Unveiling the Story Behind Dynatrace</h2>
<p>Dynatrace is a cloud-native company that focuses on analyzing machine data. Its product portfolio, delivered as software as a service, allows a client to monitor and analyze its entire IT infrastructure. Dynatrace's platform can ingest and analyze large amounts of machine-generated data in real time, allowing clients to use it for a variety of applications throughout their businesses.</p>
<h3>Dynatrace's Economic Impact: An Analysis</h3>
<p><strong>Market Capitalization:</strong> Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.</p>
<p><strong>Positive Revenue Trend:</strong> Examining Dynatrace's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>22.74%</strong> as of 31 December, 2023, showcasing a substantial increase in top-line earnings. When compared to others in the Information Technology sector, the company excelled with a growth rate higher than the average among peers.</p>
<p><strong>Net Margin:</strong> Dynatrace's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>11.69%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Dynatrace's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of <strong>2.3%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of <strong>1.48%,</strong> the company showcases effective utilization of assets.</p>
<p><strong>Debt Management:</strong> Dynatrace's debt-to-equity ratio is below the industry average at <strong>0.04</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<h2>The Significance of Analyst Ratings Explained</h2>
<p>Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.</p>
<p>Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Beyond The Numbers: 16 Analysts Discuss Dynatrace Stock

<p>In the last three months, 12 analysts have published ratings on Gilead Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>), offering a diverse range of perspectives from bullish to bearish.</p>
<p>The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">9</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Analysts have recently evaluated Gilead Sciences and provided 12-month price targets. The average target is $84.42, accompanied by a high estimate of $105.00 and a low estimate of $75.00. This current average represents a 5.15% decrease from the previous average price target of $89.00. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1713553233_0.png" alt="price target chart" /></p>
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
<p>The analysis of recent analyst actions sheds light on the perception of Gilead Sciences by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Hartaj Singh</td>
<td>Oppenheimer</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$105.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Colin Bristow</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$75.00</td>
<td>$81.00</td>
</tr>
<tr>
<td>Mohit Bansal</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$78.00</td>
<td>$84.00</td>
</tr>
<tr>
<td>Salim Syed</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Buy</td>
<td>$90.00</td>
<td>$101.00</td>
</tr>
<tr>
<td>Robyn Karnauskas</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$82.00</td>
<td>$91.00</td>
</tr>
<tr>
<td>Brian Abrahams</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$75.00</td>
<td>$76.00</td>
</tr>
<tr>
<td>Carter Gould</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$80.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Hartaj Singh</td>
<td>Oppenheimer</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$105.00</td>
<td>$115.00</td>
</tr>
<tr>
<td>Olivia Brayer</td>
<td>Cantor Fitzgerald</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$78.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Brian Abrahams</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$76.00</td>
<td>$78.00</td>
</tr>
<tr>
<td>Mohit Bansal</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$84.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Carter Gould</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$85.00</td>
<td>$82.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Gilead Sciences. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Gilead Sciences compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts explore the dynamics of price targets, providing estimates for the future value of Gilead Sciences's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
<p>Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Gilead Sciences's market position. Stay informed and make well-informed decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/GILD/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Gilead Sciences analyst ratings.</strong></a></p>
<h2>Unveiling the Story Behind Gilead Sciences</h2>
<p>Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.</p>
<h3>Understanding the Numbers: Gilead Sciences's Finances</h3>
<p><strong>Market Capitalization:</strong> Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.</p>
<p><strong>Negative Revenue Trend:</strong> Examining Gilead Sciences's financials over 3 months reveals challenges. As of 31 December, 2023, the company experienced a decline of approximately <strong>-3.72%</strong> in revenue growth, reflecting a decrease in top-line earnings. When compared to others in the Health Care sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> Gilead Sciences's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of <strong>20.09%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Gilead Sciences's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of <strong>6.33%,</strong> the company may encounter challenges in delivering satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of <strong>2.3%,</strong> the company may need to address challenges in generating satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> Gilead Sciences's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>1.09</strong>.</p>
<h2>Understanding the Relevance of Analyst Ratings</h2>
<p>Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.</p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p>If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


GILD

The Analyst Verdict: Gilead Sciences In The Eyes Of 12 Experts

<p>Analysts' ratings for Chord Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHRD#NASDAQ">CHRD</a>) over the last quarter vary from bullish to bearish, as provided by 9 analysts.</p>
<p>The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $210.33, along with a high estimate of $230.00 and a low estimate of $178.00. Witnessing a positive shift, the current average has risen by 3.27% from the previous average price target of $203.67.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1713553217_0.png" alt="price target chart" /></p>
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
<p>An in-depth analysis of recent analyst actions unveils how financial experts perceive Chord Energy. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mark Lear</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$230.00</td>
<td>$219.00</td>
</tr>
<tr>
<td>Neal Dingmann</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$224.00</td>
<td>$229.00</td>
</tr>
<tr>
<td>Nitin Kumar</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Buy</td>
<td>$195.00</td>
<td>$189.00</td>
</tr>
<tr>
<td>Mark Lear</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$219.00</td>
<td>$218.00</td>
</tr>
<tr>
<td>Derrick Whitfield</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$211.00</td>
<td>$178.00</td>
</tr>
<tr>
<td>Mark Lear</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$218.00</td>
<td>$205.00</td>
</tr>
<tr>
<td>Neal Dingmann</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$229.00</td>
<td>$224.00</td>
</tr>
<tr>
<td>Nitin Kumar</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Buy</td>
<td>$189.00</td>
<td>$188.00</td>
</tr>
<tr>
<td>Derrick Whitfield</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$178.00</td>
<td>$183.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Chord Energy. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Chord Energy compared to the broader market.</li>
<li><strong>Price Targets:</strong> Gaining insights, analysts provide estimates for the future value of Chord Energy's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Capture valuable insights into Chord Energy's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/CHRD/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Chord Energy analyst ratings.</strong></a></p>
<h2>Discovering Chord Energy: A Closer Look</h2>
<p>Chord Energy Corp is an independent exploration and production company. The company acquires, exploits, develops, and explores crude oil, natural gas, and natural gas liquids in the Williston Basin.</p>
<h3>Key Indicators: Chord Energy's Financial Health</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.</p>
<p><strong>Negative Revenue Trend:</strong> Examining Chord Energy's financials over 3 months reveals challenges. As of 31 December, 2023, the company experienced a decline of approximately <strong>-5.01%</strong> in revenue growth, reflecting a decrease in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Energy sector.</p>
<p><strong>Net Margin:</strong> Chord Energy's net margin excels beyond industry benchmarks, reaching <strong>31.5%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> Chord Energy's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of <strong>6.07%,</strong> the company may face hurdles in generating optimal returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> Chord Energy's ROA stands out, surpassing industry averages. With an impressive ROA of <strong>4.39%</strong>, the company demonstrates effective utilization of assets and strong financial performance.</p>
<p><strong>Debt Management:</strong> Chord Energy's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.11</strong>.</p>
<h2>How Are Analyst Ratings Determined?</h2>
<p>Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. </p>
<p>In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


CHRD

Unveiling 9 Analyst Insights On Chord Energy

<p><strong>Uniswap's</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/uni/usd">UNI</a>) price has increased 5.25% over the past 24 hours to <strong>$7.55</strong>, which is in the opposite direction of its trend over the past week, where it has experienced a 0.0% loss, moving from $7.58 to its current price.  As it stands right now, <strong>the coin's all-time high is $44.92</strong>. </p>
<p>The chart below compares the price movement and volatility for Uniswap over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1713553206_0.png" alt="price_chart" /></p>
<p>The trading volume for the coin has fallen 53.0% over the past week which is opposite, directionally, with the overall circulating supply of the coin, which has increased 1.78%. This brings the circulating supply to 753.77 million, which makes up an estimated 75.38% of its max supply of 1.00 billion. According to our data, the current market cap ranking for UNI is #23 at $5.69 billion.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1713553206_1.png" alt="supply_and_vol" /></p>
<p><a href="https://www.coingecko.com/en/api">Powered by CoinGecko API</a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


$UNI

Cryptocurrency Uniswap's Price Increased More Than 5% Within 24 hours

<p><strong>Virgin Galactic Holdings, Inc.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPCE#NYSE">SPCE</a>) shares are trading lower Friday after the company announced it is considering a reverse stock split with a range <a href="https://www.benzinga.com/news/24/04/38339553/why-super-micro-computer-shares-are-trading-lower-by-around-13-here-are-other-stocks-moving-in-frida">between 1-for-2 and 1-for-20.</a></p>
<p><strong>The Details:</strong></p>
<p>According to an SEC filing, Virgin Galactic will hold its 2024 annual meeting of stockholders on June 12 at 9:00 a.m ET. The company included a proposed amendment to effect a reverse stock split at a ratio ranging from any whole number between 1-for-2 and 1-for-20, as determined by the Board of Directors as one of the items to be voted on at the meeting.&nbsp;</p>
<p>Virgin Galactic shares are down nearly 40% over the past month and are trading at all-time lows Friday afternoon. According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, 25.52% of available Virgin Galactic shares are being sold short.&nbsp;</p>
<p><em>Related News: </em><a href="https://www.benzinga.com/news/24/04/38324715/whats-going-on-with-google-parent-alphabet-stock-ahead-of-earnings"><em>What&#8217;s Going On With Google Parent Alphabet Stock Ahead Of Earnings?</em></a></p>
<h2 class="wp-block-heading"><strong>Will SPCE Stock Go Up?</strong></h2>
<p>When trying to assess whether or not Virgin Galactic will trade higher from current levels, it's a good idea to take a look at analyst forecasts. </p>
<p>Wall Street analysts have an average 12-month price target of $1.5 on Virgin Galactic. The Street high target is currently at $2 and the Street low target is $1. Of all the analysts covering Virgin Galactic, no one has positive ratings, one has a neutral rating and one has a negative rating.</p>
<p>In the last month, one analyst has adjusted price targets. Here's a look at recent price target changes <a href="https://www.benzinga.com/quote/SPCE/analyst-ratings">[Analyst Ratings]</a>. Benzinga also tracks Wall Street's most accurate analysts. Check out how analysts covering Virgin Galactic have performed in recent history. </p>
<p>Stocks don't move in a straight line. The average stock market return is approximately 10% per year. Virgin Galactic is 75.3% down year-to-date. The average analyst price target suggests the stock could have further upside ahead.</p>
<p>For a broad overview of everything you need to know about Virgin Galactic Holdings, visit <a href="https://www.benzinga.com/quote/SPCE">here</a>. If you want to go above and beyond, there's no better tool to help you do just that than <a href="https://pro.benzinga.com/">Benzinga Pro</a>. Start your free trial today.</p>
<p><strong>SPCE Price Action:</strong> According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Virgin Galactic shares are down 11.6% at 85 cents at the time of publication Friday.</p>
<p><em>Image: Shutterstock</em></p>


SPCE

Why Virgin Galactic Stock Is Crashing To All-Time Lows

<p>Alcohol is losing ground to Cannabis and affecting demand in the food and beverage sectors, new research shows as  <a href="https://www.globenewswire.com/news-release/2024/04/18/2865474/0/en/36-OF-MARIJUANA-USERS-REPORT-REDUCED-ALCOHOL-CONSUMPTION-SINCE-USING-CANNABIS-PRODUCTS-NUMERATOR-REPORTS.html">Numerator</a> unveils consumer trends in cannabis. This comprehensive survey of almost 6,000 individuals who have used THC and CBD products demonstrates shifts in alcohol consumption, an uptick in spending on cannabis, and an increased focus on snacks, beverages and utilization of food delivery services.</p>
<h3 class="wp-block-heading"><strong>Main Trends&nbsp;</strong></h3>
<ul>
<li>Alcohol and cannabis behavior: The reduction in alcohol consumption among cannabis users stands out, with 36% of respondents indicating a decrease in alcohol use since they began using cannabis. Nevertheless, alcohol and cannabis are, to some extent, still functioning like complementary markets, since users are buying slightly more alcohol than non-users. (73% vs. 65%). </li>
</ul>
<ul>
<li>Average spending by customer: In terms of spending, the survey has shown that 31% of users are spending upwards of $100 monthly on THC products, due to higher frequency of consumption and pricing of selected products. </li>
</ul>
<p>Diving deeper into the specifics of consumer spending, the survey illustrates that THC users significantly outspend non-users in several grocery categories. Notably, there&#8217;s a 1.7 times higher expenditure on sports &amp; energy drinks and a 1.3 times higher expenditure on beer among THC users. This group also spends more on frozen sandwiches, spirits, frozen pizza, and frozen appetizers, showcasing a distinct preference for certain food and beverage products.</p>
<ul>
<li>Higher fast food demand: the study highlights the impact of cannabis use on preferences for fast food and delivery services. THC users are much more likely to order from food delivery apps like Doordash and Uber Eats, with a 61% higher likelihood for Doordash and a 35% higher likelihood for Uber Eats compared to non-users. This trend extends to specific fast food chains, where THC users demonstrate a higher propensity to buy from establishments like Little Caesars, Jersey Mike's Subs, and Taco Bell, among others.</li>
</ul>
<ul>
<li>Younger and lower-income customers: The survey identifies this group as using cannabis more regularly, mainly Gen Z and Millennials with incomes below $60K. They form a significant market segment with specific consumption habits and preferences. Of these, 38% are daily users with higher spending on cannabis products.</li>
</ul>
<ul>
<li>Consumer reengagement: An aspect of the study is the openness among past cannabis users to reconsider its use, with 74% indicating a willingness to use cannabis again in the future. The primary reasons for previous discontinuation include lifestyle changes (29%), a decline in enjoyment (23%) and shifting priorities (17%). This insight into consumer re-engagement potential highlights a significant opportunity for market re-entry strategies, particularly for businesses aiming to recapture or introduce products to former users.</li>
</ul>
<p>The study provides insight into consumer profiles and demand trends. Understanding these <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38254223/marijuana-investors-bet-big-on-long-term-growth-over-short-term-earnings-as-market-">trends </a>is crucial for stakeholders aiming to adapt and thrive in an evolving market environment characterized by changing preferences and consumption habits.</p>



Cannabis

Economics

Key Market Trends: Cannabis Is Impacting Alcohol Consumption And Driving Food Demand

<p>Barrington Research  analyst Gary Prestopino   maintains Snap-on (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNA#NYSE">SNA</a>) with a Outperform and maintains $325 price target.</p>


Price Target

Barrington Research Maintains Outperform on Snap-on, Maintains $325 Price Target

<p>JMP Securities  analyst Matthew Carletti   reiterates Travelers Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRV#NYSE">TRV</a>) with a Market Perform.</p>


Reiteration

JMP Securities Reiterates Market Perform on Travelers Companies

<p>HC Wainwright &amp; Co.  analyst Yi Chen   reiterates Barinthus Biotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRNS#NASDAQ">BRNS</a>) with a Buy and maintains $8 price target.</p>


BRNS

HC Wainwright & Co. Reiterates Buy on Barinthus Biotherapeutics, Maintains $8 Price Target

<p><strong>Super Micro Computer, Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) shares are falling Friday after the company announced its third quarter earnings release date and did not provide preliminary estimates as it has done in the past. </p>
<p><strong>The Details:</strong></p>
<p>Investors are concerned that the lack of quarterly preliminary estimates may be a sign of worse-than-expected financial results for SMCI.&nbsp;</p>
<p>Shares of <a href="https://www.benzinga.com/news/24/04/38323516/whats-going-on-with-chipmakers-tsmc-asml-arm-stocks">semiconductor</a> companies have been trading lower amid weakness in the technology sector and following <strong>ASML Holdings N.V.'s</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASML#NASDAQ">ASML</a>) worse-than-expected earnings report.&nbsp;</p>
<p><strong>Taiwan Semiconductor Manufacturing Company Ltd</strong>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) also reported its quarterly results earlier this week and lowered its chip market outlook as it sees consumer weakness persisting which overshadowed its Q1 results.</p>
<p>Super Micro Computer is <a href="https://www.benzinga.com/pressreleases/24/04/b38333995/supermicro-to-announce-third-quarter-fiscal-2024-earnings-on-april-30-2024">set to release</a> its third-quarter financial results after the market close on April 30 and will host a conference call to discuss the results at 5:00 p.m. ET the same day. According to estimates from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, analysts expect the company to report earnings of $5.84 per share and quarterly revenue of $4.012 billion.&nbsp;</p>
<p><em>Related News: </em><a href="https://www.benzinga.com/news/24/04/38324715/whats-going-on-with-google-parent-alphabet-stock-ahead-of-earnings"><em>What&#8217;s Going On With Google Parent Alphabet Stock Ahead Of Earnings?</em></a></p>
<h2 class="wp-block-heading"><strong>SMCI Stock Prediction 2024:</strong></h2>
<p>Equity research can be a valuable source of information for learning about a company's fundamentals. Analysts create financial models based on the fundamentals and expected future earnings of a company to arrive at a price target and recommendation for the stock.</p>
<p>Shares of Super Micro Computer have an average 1-year price target of $991.93, representing an expected upside of 31.63%.</p>
<p>Because of differences in assumptions, analysts can arrive at very different price targets and recommendations. One analyst has a bearish recommendation on Super Micro Computer, while 10 analysts have bullish ratings. The street high price target from Loop Capital is $1500, while the street low from Susquehanna is $250.</p>
<p><strong>SMCI Price Action:</strong> According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Super Micro Computer shares are down 18.4% at $757.62 at the time of publication Friday.</p>
<p><em>Image: Shutterstock</em></p>


ASML

SMCI

Why Super Micro Computer Stock Is Falling Friday

HSAI and JL among Consumer Discretionary movers

Business Update from John Kim New CEO at Volcon Inc

Volcon reports Q4 results

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Volcon</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/vlcn-stock-quote/"><strong>VLCN</strong></a></span>) just reported results for the fourth quarter of 2023.</p><ul><li>Volcon reported earnings per share of -22 cents. This was above the analyst estimate for EPS of -$60.75.</li><li>The company reported revenue of $1.08 million.</li><li>This was 36.61% worse than the analyst estimate for revenue of $1.71 million.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	<p>The post <a href="https://investorplace.com/earning-results/2024/03/vlcn-stock-earnings-volcon-for-q4-of-2023/">VLCN Stock Earnings: Volcon Beats EPS, Misses Revenue for Q4 2023</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

VLCN Stock Earnings: Volcon Beats EPS, Misses Revenue for Q4 2023

CREV

DADA

EVGO

HSAI

Press Releases

Volcon Stag Manufacturing Update December 2023

Dividends

Volcon Announces Reverse Stock Split

Management

Volcon Hires Veteran Entrepreneur to Restructure the Organization in Advance of the Stag Launch

Sports

Volcon Provides Video to Update Stag Launch

Volcon Releases Second Production Update Video

Volcon ePowersports Releases New Video of First Stag Units at Headquarters

Opinion

Thinking about buying stock in Volcon, Abeona Therapeutics, Agenus, Viking Therapeutics, or Compugen?

Volcon ePowersports Reports 2023 Operational and Financial Results

AGEN

CGEN

VKTX